Literature DB >> 1618777

Adipsin and an endogenous pathway of complement from adipose cells.

L N Choy1, B S Rosen, B M Spiegelman.   

Abstract

The alternative complement pathway is best known for its role in humoral suppression of infectious agents. We have previously shown that adipose cells synthesize adipsin, the mouse homolog of human complement factor D, and that the synthesis of this protein is reduced in several rodent models of obesity. We show here that adipose cells and adipose tissue also synthesize two other essential components of the alternative pathway of complement, factors C3 and B, and activate the proximal portion of this pathway. This activation occurs in the absence of infectious agents and without triggering the terminal, lytic part of this pathway. We demonstrate the production in vitro of several polypeptides characteristic of complement activation that are known to have potent biological activities, including the anaphylatoxin C3a. Cultured adipocytes require stimulation with cytokines to activate complement, while explanted adipose tissue has no such requirement. The adipose tissue from obese mice is deficient in this localized activation of the alternative pathway. These results indicate that complement activation occurs in a localized site, adipose tissue, in normal mice and is impaired in a state of metabolic dysfunction. This suggests a novel function for the proximal portion of this complement pathway related to adipose cell biology or energy balance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618777

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Adaptations of maternal adipose tissue to lactation.

Authors:  R G Vernon; C M Pond
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-07       Impact factor: 2.673

Review 2.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

Review 3.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 4.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

5.  Metabolic impact on serum levels of complement component 3 in Japanese patients.

Authors:  Isao Ohsawa; Hiroyuki Inoshita; Masaya Ishii; Gaku Kusaba; Nobuyuki Sato; Satoshi Mano; Kisara Onda; Tomohito Gohda; Satoshi Horikoshi; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein.

Authors:  Takayuki Fujita; Takayuki Fujioka; Tetsuo Murakami; Atsushi Satomura; Yoshinobu Fuke; Koichi Matsumoto
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 7.  [Adipocytokines as driving forces in rheumatoid arthritis].

Authors:  E Neumann; A Knedla; F Meier; I H Tarner; C Büchler; A Schäffler; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

Review 8.  Complement's hidden arsenal: New insights and novel functions inside the cell.

Authors:  M Kathryn Liszewski; Michelle Elvington; Hrishikesh S Kulkarni; John P Atkinson
Journal:  Mol Immunol       Date:  2017-02-10       Impact factor: 4.407

9.  The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.

Authors:  Julia Phieler; Kyoung-Jin Chung; Antonios Chatzigeorgiou; Anne Klotzsche-von Ameln; Ruben Garcia-Martin; David Sprott; Maria Moisidou; Theodora Tzanavari; Barbara Ludwig; Elena Baraban; Monika Ehrhart-Bornstein; Stefan R Bornstein; Hassan Mziaut; Michele Solimena; Katia P Karalis; Matina Economopoulou; John D Lambris; Triantafyllos Chavakis
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 10.  Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.

Authors:  Y Levy; J George; E Yona; Y Shoenfeld
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.